Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hak Choy

Showing results (121-130 of 140) with videos related to

Pageof 14
Sort By:
Advances in Radiation Oncology|October 14, 2021
Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell CarcinomaJonathan E Schoenhals, Osama Mohamad, Alana Christie, et al.
JAMA Oncology|June 1, 2018
Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 TrialRobert D Timmerman, Rebecca Paulus, Harvey I Pass, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 2, 2008
Summary report 7th Annual Targeted Therapies of the Treatment of Lung CancerLawrence H Einhorn, Philip Bonomi, Paul A Bunn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 2, 2013
Epidermal growth factor receptor inhibition in lung cancer: status 2012Fred R Hirsch, Pasi A Jänne, Wilfried E Eberhardt, et al.
Cancer Investigation|December 8, 2004
Trastuzumab, paclitaxel, cisplatin, and radiation for adenocarcinoma of the esophagus: a phase I studyHoward Safran, Thomas DiPetrillo, Ahmed Nadeem, et al.
Oncoimmunology|June 15, 2018
Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapyOsama Mohamad, Alberto Diaz de Leon, Samuel Schroeder, et al.
JAMA Oncology|August 12, 2021
Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non-Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical TrialPuneeth Iyengar, Elizabeth Zhang-Velten, Laurence Court, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung CancerSuresh Senan, Anthony Brade, Lu-Hua Wang, et al.
Neuro-Oncology|April 30, 2020
Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancerKenneth D Westover, J Travis Mendel, Tu Dan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 studyGlenwood D Goss, Chris O'Callaghan, Ian Lorimer, et al.
Pageof 14

Showing results (121-130 of 140) with videos related to

Sort By:
Pageof 14
Advances in Radiation Oncology|October 14, 2021
Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell CarcinomaJonathan E Schoenhals, Osama Mohamad, Alana Christie, et al.
JAMA Oncology|June 1, 2018
Stereotactic Body Radiation Therapy for Operable Early-Stage Lung Cancer: Findings From the NRG Oncology RTOG 0618 TrialRobert D Timmerman, Rebecca Paulus, Harvey I Pass, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 2, 2008
Summary report 7th Annual Targeted Therapies of the Treatment of Lung CancerLawrence H Einhorn, Philip Bonomi, Paul A Bunn, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 2, 2013
Epidermal growth factor receptor inhibition in lung cancer: status 2012Fred R Hirsch, Pasi A Jänne, Wilfried E Eberhardt, et al.
Cancer Investigation|December 8, 2004
Trastuzumab, paclitaxel, cisplatin, and radiation for adenocarcinoma of the esophagus: a phase I studyHoward Safran, Thomas DiPetrillo, Ahmed Nadeem, et al.
Oncoimmunology|June 15, 2018
Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapyOsama Mohamad, Alberto Diaz de Leon, Samuel Schroeder, et al.
JAMA Oncology|August 12, 2021
Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non-Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical TrialPuneeth Iyengar, Elizabeth Zhang-Velten, Laurence Court, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
PROCLAIM: Randomized Phase III Trial of Pemetrexed-Cisplatin or Etoposide-Cisplatin Plus Thoracic Radiation Therapy Followed by Consolidation Chemotherapy in Locally Advanced Nonsquamous Non-Small-Cell Lung CancerSuresh Senan, Anthony Brade, Lu-Hua Wang, et al.
Neuro-Oncology|April 30, 2020
Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancerKenneth D Westover, J Travis Mendel, Tu Dan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 studyGlenwood D Goss, Chris O'Callaghan, Ian Lorimer, et al.
Pageof 14